The World Health Organization (WHO) on Monday May 25, announced that it has suspended the use of hydroxychloroquine in solidarity trial for the treatment of COVID-19.    The drug trial was suspended on grounds of safety concern following a report published by Lancet, which revealed that more people are dying from the use of hydroxychloroquine to combat COVID-19.   WHO Director General Tedros Adhanom Ghebreyesus who made the announcement during an online briefing, added that other aspects of the WHO solidarity trial would continue. …